Vijay Pande (L) and Jorge Conde

Is this Sil­i­con Val­ley duo the fu­ture of biotech?

SAN FRAN­CIS­CO — Sev­en years ago, Sil­i­con Val­ley’s brash­est ven­ture cap­i­tal­ist in­vit­ed a soft-spo­ken Stan­ford bio­physi­cist out for pan­cakes not far from here, plan­ning to make a re­quest he pub­licly swore he’d nev­er make.

By that point, Marc An­dreessen had al­ready com­plet­ed his rise from tech prince — Time mag­a­zine lit­er­al­ly put him on the cov­er on a throne in 1996 — to tech king­mak­er. The ba­by-faced founder of Netscape, briefly the world’s dom­i­nant web brows­er, re-emerged in 2009 as head of An­dreessen Horowitz, or a16z for short, that quick­ly be­came one of the in­dus­try’s most sought-af­ter VC firms.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.